Diabetes drug metformin 'may help reverse breast cancer drug resistance'

Diabetes drug metformin 'may help reverse breast cancer drug resistance'
 

Scientists found that metformin, used to treat type 2 diabetes, reduced the proliferation of tumour cells in the laboratory.
It also prevented or delayed resistance to the chemotherapy drug doxorubicin.
Other laboratory experiments and tests on mice showed that metformin reversed protein markers associated with multiple drug resistance (MDR).
This meant the drug might help resistant breast cancers to start responding to treatment again, said the researchers.
Previous work has shown that metformin has an anti-proliferative effect on many kinds of cancer cell, they added.
Multiple-study... read more

 
Friday, 12:02 in Health, Views: 40
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31